Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 158.39 USD -0.93% Market Closed
Updated: Aug 14, 2024
Have any thoughts about
Johnson & Johnson?
Write Note

Relative Value

The Relative Value of one JNJ stock under the Base Case scenario is hidden USD. Compared to the current market price of 158.39 USD, Johnson & Johnson is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

JNJ Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
68
vs Industry
30
Median 3Y
5
Median 5Y
4.6
Industry
2.4
Forward
4.3
vs History
92
vs Industry
37
Median 3Y
22.9
Median 5Y
22.7
Industry
22.1
Forward
15.6
vs History
73
vs Industry
26
Median 3Y
18.1
Median 5Y
16.8
Industry
16.4
vs History
88
vs Industry
11
Median 3Y
20.4
Median 5Y
18.7
Industry
22.8
vs History
79
vs Industry
14
Median 3Y
5.7
Median 5Y
5.7
Industry
2
vs History
55
vs Industry
27
Median 3Y
5.1
Median 5Y
4.6
Industry
2.5
Forward
4.4
vs History
66
vs Industry
33
Median 3Y
7.5
Median 5Y
6.9
Industry
5.1
vs History
76
vs Industry
31
Median 3Y
14
Median 5Y
14
Industry
13.1
Forward
12.7
vs History
80
vs Industry
28
Median 3Y
18.3
Median 5Y
18.9
Industry
16.5
Forward
14.2
vs History
68
vs Industry
26
Median 3Y
18
Median 5Y
17.1
Industry
15.2
vs History
66
vs Industry
20
Median 3Y
21.8
Median 5Y
20.2
Industry
18
vs History
74
vs Industry
28
Median 3Y
2.9
Median 5Y
2.8
Industry
1.9

Multiples Across Competitors

JNJ Competitors Multiples
Johnson & Johnson Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Johnson & Johnson
NYSE:JNJ
381.2B USD 4.4 10 12.3 15.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
863B USD 22.2 117.5 58.7 65.8
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 16.5 45.2 33.7 37
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Merck & Co Inc
NYSE:MRK
290.1B USD 4.6 21.1 14.2 17.5
UK
AstraZeneca PLC
NASDAQ:AZN
258.5B USD 5.3 40.1 18.3 27.4
CH
Roche Holding AG
SIX:ROG
221.6B CHF 3.8 19.3 10.8 12.8
CH
Novartis AG
SIX:NOVN
191.1B CHF 4.5 13.7 10.8 16
US
Pfizer Inc
NYSE:PFE
163.5B USD 2.9 -63 12.7 20.5
IE
Endo International PLC
LSE:0Y5F
148.4B USD 64 -50.8 238.1 597
P/E Multiple
Earnings Growth
US
Johnson & Johnson
NYSE:JNJ
Average P/E: 38.1
10
-22%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
117.5
341%
DK
Novo Nordisk A/S
CSE:NOVO B
45.2
90%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Merck & Co Inc
NYSE:MRK
21.1
7 668%
UK
A
AstraZeneca PLC
NASDAQ:AZN
40.1
174%
CH
Roche Holding AG
SIX:ROG
19.3
29%
CH
Novartis AG
SIX:NOVN
13.7
20%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -63
693%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -50.8 N/A

See Also

Discover More
Back to Top